Issuu

WilliamAlanHaseltine

https://www.williamhaseltine.com

1966 B.A.,UniversityofCalifornia(PhysicalChemistry)

1973 Ph.D.,HarvardUniversity(Biophysics,JamesD.Watson,WalterGilbert)

1973-1975 MassachusettsInstituteofTechnology,PostdoctoralFellow,CenterforCancer Research,Cambridge,(DavidBaltimore)

EMPLOYMENT:

2005-present Chair,ACCESSHealthInternational,Inc.

2003-present Chair,TheHaseltineFoundationforScienceandtheArts 2005-2010 Chairman,HaseltineGlobalHealth,LLC

1993-2004 ChairmanandCEO,HumanGenomeSciences,Inc.

ACADEMICANDMAJORVISITINGAPPOINTMENTS:

2023-present

2008-2012

2008-2010

2006-2008

2004-2010

ProfessorandProgramDirectorinRegenerativeMedicine,TheFeinstein InstitutesofMedicalResearch

MemberoftheBoardofTrustees,InstituteofHumanVirology,Universityof Maryland

AdjunctProfessor,InstituteofChemicalEngineering,UniversityofMumbai, India

ChairmanoftheBoardofTrustees,UniversityofCalifornia,Berkley,Centerfor SyntheticBiology

AdjunctProfessor,TheScrippsInstituteofMedicalResearch

1989-1995 Professor,DepartmentofCancerBiology,HarvardSchoolofPublicHealth

1988-1995 Professor,DivisionofHumanRetrovirology,Dana-FarberCancerInstitute

1988-1995 Professor,DepartmentofPathology,HarvardMedicalSchool

1988-1994 HarvardAIDSInstitute:SteeringCommittee

1988-1993 Chief,DivisionofHumanRetrovirology,Dana-FarberCancerInstitute

1981-1988 Chief,LaboratoryofBiochemicalPharmacology,Dana-FarberCancerInstitute

1979-1988

AssociateProfessor,DepartmentofPathology,HarvardMedicalSchool, Dana-FarberCancerInstitute

AssociateProfessor,DepartmentofCancerBiology,HarvardSchoolof Public Health

1982 VisitingProfessor,UniversityofKyoto

1980-1981

Chief,LaboratoryofMolecularStudiesofCancerCauseandTreatment, Dana-FarberCancerInstitute

1978-1979 AssistantProfessor,DepartmentofCancerBiology,HarvardSchoolofPublic Health

1975-1978

AssistantProfessor,DepartmentofPathology,HarvardMedicalSchool, Dana-FarberCancerInstitute

1973 VisitingProfessor,UniversityofCopenhagen,InstituteofMicrobiology

TEACHINGEXPERIENCE:

1985-1993 NewPathwaysInstructorforHarvardMedicalSchool

1992 Virology202,MolecularBiologyoftheAIDSVirus,HarvardMedicalSchooland HarvardSchoolofPublicHealth

1990 AIDS1990,ACourseforScandinaviaAIDSresearchMay7-9,1990.

1990 GeneRegulationConference,HarvardAIDSInstitute,November5-7,Organizer andChair

1981-1988 CellBiology212,AdvancedTopicsinCancerResearch,HarvardMedicalSchool andHarvardSchoolofPublicHealth

1975-1981 BiologyofCancer,HarvardCollege

1977-1980 BiologyofCancer219,DepartmentofBiophysics,HarvardSchoolofPublicHealth

1976-1978 Microbiology,HarvardMedicalSchool

1969-1973 BiologyandSocialIssues,HarvardCollege

BUSINESSandCONSULTINGEXPERIENCE:

2024-present OxiaBiosystems:ScientificAdvisor

2024-present Libera:ScientificAdvisor

2024-present RationalVaccines:ScientificAdvisoryMember

2024-present ADvantage:ScientificAdvisoryMember

2024-present CoRegen:BoardofDirectorsMember

2023-present VectorSciences:ScientificAdvisoryMember

2023-present GennovaBiopharmaceutical

2016-2024 X-Vax:Founder

2016-2024 Demetrix:Founder

2008-2017 RelianceIndustries(RIL):InnovationCouncil(India)

2005-2009 CodexisPharmaceuticals:Advisor

2005-2009 CMEA,Inc.:Consultant

2005-2009 TheDNARepairCompany,Inc.:Advisor

2004-2007 MatrixScientific: ChairmanofAdvisoryBoard(India) 1993-2004 HumanGenomeSciences,Inc.Founder,Chairman,CEO.

1987-2001 HealthCareInvestmentCo:ScientificAdvisor

1994-2000 Diversa,Inc.:Founder

1992-1998 LeukoSite,Inc.:Founder

1992-1998 ProScript,Inc.:Founder

1992-1993 DendreonCorporation,Inc:(FormerlyActivatedCellTherapy)Founder

1990-1993 VirusResearchInstitute,Inc: Founder

1986-1993 SmithKlineSquibb,Consultant.

1987-1990 Sandoz,Consultant.

1988-1989 ScheringPlough,Consultant.

1981-1986 CambridgeBioSciences,Inc:Founder

AWARDSandHONORS:

2024 MarquisWho’sWhoTopScientists&IndustryLeader

2023 InstituteofHumanVirologyLifetimeAchievementAward

2013 DistinguishedAchievementAward,LupusFoundationofAmerica

2010 YoungConcertArtistsHonor

2010 LotusClubAwardofDistinction

2010 AIDforAIDS2010MyHeroAward

2005 S.L.E.LupusFoundationGalaScientificHonoree,NewYork

2005 GenomeValleyExcellenceAwardatBioAsia,India

2004 HonoraryDoctorateofScience,UniversityofMaryland

2003 WashingtonBusinessForward,“The2002ForwardForty”

2002 HonoraryDoctorateofScience,UniversityofPortsmouth,UK

2001 TimeMagazine“25MostInfluentialGlobalBusinessExecutives”

2001 WashingtonAcademyofSciences“HealthSciencesAwardforScientific Achievement”

2001

KPMG/TechwayMagazineGreaterWashingtonHighTechAward,“Technology LegendsAward”

2000 BostonUniversity,F.A.BourkeDistinguishedLectureinBiotechnology

2000 MarylandHigh-TechCouncil“FirmoftheYearAward”

1996 KPMGHighTechEntrepreneuroftheYearAward,Washington

1996 Ernst&YoungGreaterWashingtonEntrepreneuroftheYearAward

1995 AmericanAcademyofAchievementGoldenPlateAward

1995 BurdenCenterAwardforBusinessLeadership

1994 WashingtonianMagazine,"WashingtonBusinessLeaderoftheYear"

1991-1993BristolMyersSquibbUnrestrictedResearchAward

1987 LeukemiaSocietyofAmerica,Inc.fordistinguishedserviceasamemberofthe NationalBoardofTrustees

1986 Governor'sAIDSRecognitionAward

1978-1982AmericanCancerSocietyFacultyResearchAward

1975-1976RuthEstrinGoldbergMemorialSocietyAward

1973-1975HelenHayWhitneyFellow

1964-1966RegentFellow,UniversityofCalifornia

1965 PhiBetaKappa-Junioryearexceptionalhonor

ASSOCIATIONSANDBOARDS:

2024-present NominatingCommitteeMember,Phillip&PatriciaFrostMuseumofScience

2024-present Chair,ProgramCommittee,Phillip&PatriciaFrostMuseumofScience

2024-present ExecutiveCommitteeMember,Phillip&PatriciaFrostMuseumofScience

2024-present BoardMember,Phillip&PatriciaFrostMuseumofScience

2024-present EditorialBoardmember,IJMS

2024-present EditorialBoardmember,MDPI

2019-2025 ChumirFoundationforEthicsinLeadership,InternationalAdvisoryBoard

2019-2025 Genomes2PeopleResearchProgramAdvisoryBoard

2018-2023 PatronoftheMetropolitanOpera

2014-2024 PatronMuseumofModernArt

2014-present PatronMetropolitanMuseum(President’sCouncil,2005-2012)

2014-2024 PatronoftheWhitneyMuseum

2013-2023 PatronoftheGuggenheimMuseum

2010-present LifescienceFoundation,Director

2008-2025 BoardofDirectorsofYoungConcertArtists

2008-present BoardofDirectorsoftheYouthOrchestraoftheAmericas

2008-2025 HonoraryTrustee,BrookingsInstitution

2007-present LifetimeMemberoftheBoardofGovernors,NewYorkAcademyofSciences

2006-2023 Patron,AsiaSociety,MemberofthePresident’sCouncil(1995-2000)

2005-present MemberoftheWorldAcademyofArtandScience

2003-present Member,CouncilonForeignRelations

2002-2015 Member,AspenInstituteItalia

2001-2015 Cloning&StemCellsJournal,Member,EditorialBoard

2000-2015 TheJournalofStemCellResearch,Editor

2011-2018

MemberoftheAdvisoryCounciloftheMaxInstituteofHealthcareand ManagementIndianSchoolofBusiness

2011-2018 MemberoftheAdvisoryBoardofTheRagonInstitute,Cambridge,Mass

2010-2018 AdvisoryBoardoftheMetropolitanOpera

2006-2018 MemberoftheJapanSociety

2009-2017

MemberoftheAdvisoryCounciloftheKochInstituteofIntegrativeBiology, MIT

1998-2004 ChairoftheBoardoftheSmithsonianMuseumofAmericanHistory

1997-2002 ChairmanoftheBoardforNaturalHistoryMuseum

1995-2015 BusinessExecutivesforNationalSecurity

PROFESSIONALSOCIETYMEMBERSHIPS:

AmericanAssociationfortheAdvancementofScience(AAAS)

AmericanAcademyofAnti-AgingMedicine

AmericanAssociationforCancerResearch(AACR)

AmericanSocietyforBiochemistryandMolecularBiology

NewYorkAcademyofSciences

PhilosophicalSocietyofWashingtonDC

TheAcademyofAmericanPoets

SocietyforTissueEngineeringandRegenerativeMedicine(Founder)

PUBLICATIONS:

Sinceearly2020,WilliamHaseltinehasbeenpublishedwidelyasanauthorityontheCovid-19 pandemicinCNN,WashingtonPost,Forbes,andScientificAmerican.Heisaregularcontributor toForbes,withover1000articlespublishedsince2018,andmaintainedabi-monthlycolumnfor InsidePrecisionMedicineforsometime.Hehaspublishedover16Op-EdsforTheHill,over20 Op-EdsforProjectSyndicate,andover50articlesforPsychologyToday.

Recent Notable Books

1. HaseltineWA,HazelK.Destiny’sChildNoLonger:RewritingGeneticFate.ACCESS HealthPress.2025.

2. HaseltineWA,RathK.LiveLonger:WhatYouCanDo,WhatMedicineCanDo. ACCESSHealthPress.2025.

3. HaseltineWA,ThomasA.CheckpointInhibitors:AKeytoCuringCancer.ACCESS HealthPress.2025.

4. HaseltineWA,McCombsG.FUSION!MeldingofHumanandMachineIntelligence. ACCESSHealthPress.2024.

5. HaseltineWA,PatarcaR.MolecularBiologyofSARS-CoV-2:Opportunitiesfor AntivirusDrugDevelopmentWoltersKluwer2024.

6. HaseltineWA,HazelK.BetterEyesight:WhatYouandModernMedicineCanDoto ImproveYourVision..ACCESSHealthPress.2024.

7. HaseltineWA,PatarcaR.TheCOVID-19Textbook:Science,MedicineandPublic HealthWoltersKluwer2023.

8. HaseltineWA,VarnerK.EndingHepatitisC:ASeven-stepPlanforaSuccessful EradicationProgram:ARoadmapforEndingEndemicDiseaseGlobally ACCESS HealthPress.2023.

9. HaseltineWA,ThomasA.CART:ANewCureforCancer,AutoimmuneandInherited Disease.ACCESSHealthPress.2023.

10.HaseltineWA,RathK.ViroidsandVirusoids:Nature’sOwnmRNAs.ACCESSHealth Press.2023.

11. HaseltineWA.TheFutureofMedicine:HealingYourself:RegenerativeMedicinePart One.ACCESSHealthPress.2023.

12.HaseltineWA,McCombsG.MonoclonalAntibodies:TheOnceandFutureCurefor Covid-19.ACCESSHealthPress.2023.

13.HaseltineWA.AFamilyGuidetoLongCovid:Questions&Answers.ACCESSHealth Press.2022.

14.HaseltineWA.Omicron:FromPandemictoEndemic:TheFutureofCovid-19.ACCESS HealthPress.2022.

15.HaseltineWA.NaturalImmunityandCovid-19:WhatitisandHowitCanSaveYour Life.ACCESSHealthPress.2022.

16.HaseltineWA.Variants!TheShape-shiftingChallengeofCovid-19.4th Edition.ACCESS HealthPress.2021.

17.HaseltineWA.CovidRelatedPostTraumaticStressDisorder,CV-PTSD:WhatItIsand WhatToDoAboutIt.ACCESSHealthPress.2021.

18.HaseltineWA.ScienceAsASuperpower:MyLifelongFightAgainstDiseaseandthe HeroesWhoMadeItPossible.ACCESSHealthPress.2021.

19.HaseltineWA.MyLifelongFightAgainstDisease:FromPolioandAIDStoCovid-19. MascotBooks.2020.

20.HaseltineWA.ACovidBackToSchoolGuide:Questions&AnswersforParentsand Students.ACCESSHealthPress.2020.

21.HaseltineWA.AFamilyGuidetoCovid:Questions&AnswersforParents, Grandparents,andChildren.ACCESSHealthPress.2020.

22.HaseltineWA.StayYoungNavigators:ThePursuitofActiveAgingandSeniorsCaring forSeniors.ACCESSHealthPress.2020.

23.HaseltineWA,DirksenA.VoicesinDementiaCare:ReimaginingtheCultureofCare. GreenleafBookGroup.2020.

24.HaseltineWA,GalianaJ. AgingWell:SolutionstotheMostPressingGlobalHealth ChallengesofAging[paperback] GreenleafBookGroup.2020.

25.HaseltineWA,GalianaJ. AgingWell:SolutionstotheMostPressingGlobalHealth ChallengesofAging[hardcover]. PalgraveMacmillan.2019.

26.HaseltineWA. WorldClass:AStoryofAdversity,Transformation,andSuccessatNYU LangoneHealth. FastCompanyPress. 2019.

27.HaseltineWA.EverySecondCounts:SavingLiveswithIndia’sEmergencyResponse System.BrookingsInstitutionPress,TethysPressIndia.2018.

28.WidenS,HaseltineWA.AgingwithDignity:InnovationandChallengeisSweden-The VoiceofCareProfessionals.NordicAcademicPress.2017.

29.HaseltineWA.AffordableExcellence:TheSingaporeHealthcareStory.Brookings InstitutionPress,RidgeBooksSingapore.2013.

Original Reports

1. ShirkJ,HaseltineWA,PimentalGC.SintonBandsEvidenceforDeuteratedWateron Mars. Science. 1965. 147:48-49

2. StephansonJC,HaseltineWA,MooreCB.AtmosphericAbsorptionofCO2 Laser Radiation. AppliedPhysicsLetters. 1967. 11:164-166.

3. HaseltineWA.InVitroTranscriptionofEscherichiacoliRibosomalRNAGenes. Nature. 1972. 235:329-333.

4. HaseltineWA,BlockR,GilbertW,WeberK.MSIandMSIIMadeontheRibosomein IdlingStepofProteinSynthesis. Nature.1972. 238:381-384.

5. HaseltineWA,BlockR.SynthesisofGuanosineTetra-andPenta-phosphateRequiresthe PresenceofCodonSpecificUnchargedTransferRibonucleicAcidintheAcceptorSiteof Ribosomes. Proc.Natl.Acad.Sci. 1974. 70:1564-1568.

6. BlockR,HaseltineWA.ThermolobilityoftheStringentFactorinrelMutantsof Escherichiacoli. J.Mol.Biol. 1973. 77:625-629.

7. FreisenJD,FiilNP,ParkerJM,Haseltine,WA. ANewRelaxedMutantofEscherichia coliwithanaltered50sRibosomalSubunit. Proc.Natl.Acad.Sci. 1974. 71: 3465-3469.

8. BlockR,HaseltineWA. PurificationandPropertiesofStringentFactor.J.Biol.Chem. 1974. 250:1212-1217.

9. PanetA,HaseltineWA,BaltimoreD,PetersG,HaradaF,DahlbergS.SpecificBinding ofTryptophanTransferRNAtoAvianMyeloblastosisVirusReverseTranscriptase. Proc. Natl.Acad.Sci. 1975. 72:2525-2539.

10.HaseltineWA,BaltimoreD.SizeofMurineRNATumorVirus-specificNuclearRNA Molecules. J.Virol. 1976. 19:331-340.

11. HaseltineWA,KleidD,PanetA,RothenbergE,BaltimoreD.OrderedTranscriptionof RNATumorVirusesbyReverseTranscriptaseInVitro. J.Mol.Biol. 1976. 106: 109-131.

12.RoseJ,HaseltineWA,BaltimoreD. 5'-TerminusofMoloneyMurine LeukemiaVirus 35s RNAism7G5ppp5'GmpCp. J.Virol. 1976. 20:324-329.

13.PetersG,HaradaF,DahlbergJE,HaseltineWA,PanetA,BaltimoreD.Identificationof RNAPrimerofDNASynthesisofMoloneyMurineLeukemiaVirus.J.Virol.1977 21:103

14.HaseltineWA,MaxamA,GilbertW.TheRousSarcomaVirusGenomeisTerminally Redundantthe5'Sequence. Proc.Natl.Acad.Sci.1977. 74:989-993.

15.CoffinJ,HaseltineWA. TerminalRedundancyandtheOriginofReplicationofRous SarcomaVirusRNA. Proc.Natl.Acad.Sci. 1977. 74:1908-1912.

16.HaseltineWA,PanetA,SmolerD,BaltimoreD,PetersG,HaradaF,DahlbergJ. InteractionofAMVReverseTranscriptaseandtRNAtrp Biochem.1977. 16:3625-3632.

17.CoffinJ.HaseltineWA. NucleotideSequenceofRousSarcomaVirusRNAatthe InitiationSiteofDNASynthesis. J.Mol.Biol. 1977. 117:805-814.

18.CoffinJM,HagemanRC,MaxamAM,HaseltineWA. StructureoftheGenomeof MoloneyMurineLeukemiaVirus:ATerminallyRedundantSequence. Cell. 1978. 13: 761773.

19.HaseltineWA,KleidDG. AMethodforClassificationof5'TerminalofRetroviruses. Nature. 1978. 273:358-364.

20.TronickSA,CabradillaSA,AaronsonSA,HaseltineWA. 5'TerminalNucleotide SequencesofMammalianTypeCHelperVirusesareConservedintheGenomesof ReplicationDefectiveMammalianTransformingViruses. J.Virol. 1978. 26:570-576.

21.D`AndreaAD,HaseltineWA. SequenceCleavageofDNAbytheAnti-tumorAntibiotics NeocarzinostatinandBleomycin. Proc.Natl.Acad.Sci. 1978. 75:3608-3612.

22.D'AndreaAD,HaseltineWA. ModificationofDNAbyAflatoxinB1 Creates Alkali-LabileLesionsinDNAatPositionsofGuanineandAdenine. Proc.Natl.Acad. Sci.1978. 75:41204124.

23.DesselbergerU,NakajimaK,AlfinoP,PedersenFS,HaseltineWA,HannounC,Palaese P. BiochemicalEvidenceThat"New"InfluenzaVirusStrainsinNaturemayAriseby Recombination. Proc.Natl.Acad.Sci. 1978. 75:341-3345.

24.ReitzMSJr,Wong-StaalF,HaseltineWA,KleidDG,TrainerCD,GallagherRE,Gallo RC. GibbonApeLeukemiaVirusHall'sIsland:NewStrainofGibbonApeLeukemia Virus. JVirol.1979. 29:395-400.

25.HaseltineWA,CoffinJM,HagemanTC. StructureofProductoftheMoloneyMurine LeukemiaVirusEndogenousDNAPolymeraseReaction. J.Virol.1979. 30:375-383.

26.SahaganBG,HaseltineWA. StructuralAnalysisoftheGenomesofWoollyMonkeyand GibbonApeLeukosisViruses. JVirol. 1979. 31:657-667.

27.HaseltineWA,LoKM,D'AndreaAD. PreferredSitesofStrandScissioninDNA Modifiedbyanti-DiolEpoxideofBenzo(a)pyrene. Science. 1980. 209:929-931.

28.HaseltineWA,GordonLK,LindanCP,GrafstromRH,ShaperNL,GrossmanL. CleavageofPyrimidineDimersinSpecificDNASequencesbyaPyrimidineDimer DNA-GlycosylaseofM.luteus. Nature. 1980. 285:634-641.

29.RosenbergZR,HaseltineWA. ATransfectionAssayforTransformationbyFeline SarcomaVirusProviralDNA. Virology. 1980. 102:240-244.

30.SahagenBG,HaseltineWA. RelationshipofRetrovirusesIsolatedfromLeukemia TissuestotheWoolly-Monkey-GibbonApeLeukemiaViruses.J.Virology. 1980. 34: 390-401.

31.PedersenFS,HaseltineWA. AnalysisoftheGenomeofanEndogenous,Ecotropic RetrovirusoftheAKRStrainofMice:MicromethodforDetailedCharacterizationof HighMolecular-WeightRNA. J.Virol. 1980. 33:349-365.

32.RosenbergZF,PedersenFS,HaseltineWA. ComparativeAnalysisoftheGenomesof FelineLeukemiaViruses. J.Virol. 1980. 35:542-546.

33.ClementsJE,PedersenFS,NarayanO,HaseltineWA. GenomicChangesAssociated withAntigenicVariationofVisnaVirusduringPersistentInfection. Proc.Natl.Acad. Sci. 1980. 77:4454-4458.

34.PedersenFS,BuchhaganDL,ChenCY,HaysEF,HaseltineWA. Characterizationof VirusProducedbyaLymphomaInducedbyInoculationofAKRMCF-247Virus. J. Virol. 1980. 35:211-218.

35.GordonLK,HaseltineWA. ComparisonoftheCleavageofPyrimidineDimersbythe BacteriophageT4andM.luteusUV-SpecificEndonucleases. J.Biol.Chem. 1980. 255: 1204712050.

36.GrunbergSM,HaseltineWA. UseofanIndicatorSequenceofHumanDNAtoStudy DNADamagebyMethylbis(2-chloreothyl)amine. Proc.Natl.AcadSci. 1980. 77: 6546-6550.

37.BuchhaganDL,PedersenFS,CrowtherRL,HaseltineWA. MostSequenceDifferences BetweentheGenomesoftheAKVVirusandaLeukemogenicGross AVirusPassaged InVitroarelocatedNearthe3'Terminus. Proc.Natl.Acad.Sci. 1980. 77:4359-4363.

38.PedersenFS,CrowtherRL,TenneyDY,ReimoldAM,HaseltineWA.Novel LeukemogenicRetrovirusesIsolatedfromCellLineDerivedfromSpontaneousAKR Tumor. Nature. 1981. 292:167-170.

39.MartinRF,HaseltineWA.RangeofRadiochemicalDamagetoDNAwithDecayof Iodine125.Science. 1981. 213:896-898.

40.RosenbergZF,CrowtherRL,EssexM,JarrettO,HaseltineWA. IsolationVia TransfectionofFelineLeukemiaVirusesfromDNAofNaturallyOccurringFeline Lymphomas. Virology. 1981. 115:203-210.

41.RosenbergZF,SahaganBG,SnyderHW,WorleyMB,EssexM,HaseltineWA. BiochemicalCharacterizationofCellstransformedViaTransfectionbyFelineSarcoma VirusProviralDNA. JVirol.1981. 38:782-788.

42.RosenbergZF,SahagenBG,WorleyMB,EssexM,HaseltineWA. Transformationwith SubgenomicFragmentsofFelineSarcomaVirusProviralDNA. Virology.1981. 112: 496-504.

43.BerlinV,HaseltineWA. ReductionofAdriamycintoaSemiquinoneFeeRadicalby NAHPHCytochromeP-450ReductaseProducesDNACleavageinaReactionMediated byMolecularOxygen. J.Biol.Chem. 1981.256:4747-4756.

44.GordonLK,HaseltineWA. EarlyStepsofExcisionRepairofCyclobutanePyrimidine DimersbytheMicrococcusLuteusEndonuclease;AThreeStepIncisionModel. J.Biol. Chem. 1981. 256:6608-6616.

45.LipkeJA,GordonLK,Brash,DE,HaseltineWA. DistributionofUltravioletLight InducedDamageinaDefinedSequenceofHumanDNA: DetectionofAlkaline SensitiveLesionsatPyrimidine-Nucleoside-CytidineSequences. Proc.Natl.Acad.Sci. 1981. 78:33883392.

46.GordonLK,HaseltineWA.QuantitationofCyclobutanePyrimidineDimerFormationin DoubleandSingleStrandedDNAFragmentsofDefined Sequences. Radiation Research. 1982. 89:99-112.

47.Royer-PokoraB,GordonLK,HaseltineWA. UseofExonucleaseIIItoDeterminethe SiteofStableLesionsinDefinedSequencesofDNA;TheCyclobutanePyrimidine DimerandcisandtransDichloradiamminePlatinumIIExamples. NucleicAcids Research. 1982. 9:4595-4609.

48.PedersenFS,CrowtherRL,HaysEF,NowinskiRC,HaseltineWA. Structureof RetroviralRNAsProducedbyCellLinesDerivedfromSpontaneous Lymphomasof AKRMice. J.Virol. 1982. 41: 18-29.

49.LenzJ,CrowtherR,StraceskiA,HaseltineWA. NucleotideSequencesoftheAkvenv Gene. J.Virol. 1982. 42:519-529.

50.TrusMD,SodroskiJG,HaseltineWA. IsolationandCharacterizationofaHumanLocus HomologoustotheTransformingGene(v-fes)ofFelineSarcomaVirus. J.Biol. Chem. 1982. 257:2730-2733.

51.KrossJ,HennerWD,HechtSM,HaseltineWA. SpecificityofDeoxyribonucleicAcid CleavagebyBleomycin,PhleomycinandTallysomycin. Biochem. 1982. 21: 4310-4318.

52.KrossJ,HennerWD,HaseltineWA,RodriguezL,LevinM,HechtSM.StructuralBasis fortheDNAAffinityofBleomycins. Biochem.1982. 21:3711-3721.

53.BrashDE,HaseltineWA.UltravioletLightInducedMutationHotspotsOccuratDNA DamageHotspots. Nature. 1982. 298:189-192.

54.LenzJ,CrowtherR,KlimenkoS,HaseltineWA.MolecularCloningofaHighly Leukemogenic,EcotropicRetrovirusfromanAKRMouse. J.Virol.1982. 43:943-951.

55.HennerWD,GrunbergSM,HaseltineWA. SitesandStructureofGammaRadiation InducedDNAStrandBreaks. J.Biol. Chem.1982. 257:11750-11754.

56.FranklinWA,LoKM,HaseltineWA.AlkalineLabilityofFluorescentPhotoproductsin UltravioletLight-irradiatedDNA. J.Biol.Chem. 1982. 257:13535-13543.

57.HennerWD,RodriguezLO,HechtSM,HaseltineWA. GammaRayInduced DeoxyribonucleicAcidStrandBreaks:3'GlycolateTermini.J.Biol.Chem.1983. 258: 711-713.

58.Romet-LemoneJL,McLaneMF,ElfassiE,HaseltineWA,AzocarJ,EssexM. Hepatitis B.VirusInfectioninaHumanLymphoblastoidCellCulture. Science. 1983. 221: 667-669.

59.LenzJ,HaseltineWA. LocalizationoftheLeukemogenicDeterminantsofSL3-3,an Ecotropic,XC-Positive,MurineLeukemiaVirusofAKROrigin. J.Virology. 1983. 47: 317328.

60.HennerWD,GrunbergSM,HaseltineWA.EnzymeActionat3'TerminiofIonizing Radiation-inducedDNAStrandBreaks. J.Biol.Chem.1983. 258:15198-15205.

61.LenzJ,CelanderD,CrowtherRL,PatarcaR,PerkinsDW,SheldonA,HaseltineWA. EnhancerSequencesthatDetermineLeukemogenicityofaMurineRetrovirus. Nature. 1984. 308:467-470.

62.Royer-PokoraB,PedersenW,HaseltineWA. BiologicalandBiochemical CharacterizationofanSV40TransformedXerodermaPigmentosumCellLine. Exp. CellRes. 1984. 151:408-420.

63.FreiE,RosowskyA,WrightJE,CucchiCA,LippkeJA,ErvinTJ,JolivetJ,Haseltine WA. DevelopmentofMethotrexateResistanceinaHumanSquamousCellCarcinomaof theHeadandNeckinCulture. Proc.Natl.Acad.Sci. 1984. 81:2873-2877.

64.ElfassiE,Romet-LemonneJL,EssexM,Frances-McLaneM,HaseltineWA. Evidence ofExtrachromosomalFormsofHepatitisBViralDNAinBoneMarrowCulture ObtainedfromaPatientRecentlyInfectedwithHepatitisBVirus. Proc.Natl.Acad.Sci. 1984. 81:3526-3528.

65.DeLucaD,DoetschPW,HaseltineWA. ConstructionofaMammalianExpressionVector fortheE.coliuvrA,b,andCGenes. Plasmid. 1984. 11:253-259.

66.SodroskiJG,GohWC,HaseltineWA. TransformingPotentialoftheHumancfps/fes Locus. Proc.Natl.Acad.Sci. 1984. 81:3039-3043.

67.SodroskiJG,TrusM,PerkinsD,PatarcaR,Wong-StaalF,GelmanE,GalloR,Haseltine WA. RepetitiveStructureintheLongTerminalRepeatElementofaTypeIIHumanT CellLeukemiaVirus. Proc.Natl.Acad.Sci. 1984. 81:4617-4621.

68.FranklinWA,HaseltineWA. RemovalofUVLight-inducedPyrimidine-Pyrimidone (6-4)ProductsfromEscherichiacoliDNARequirestheuvrA,uvrB,anduvrCGene Products. Proc.Natl.Acad.Sci.1984. 81:3821-3824.

69.SageE,HaseltineWA. HighRatioofAlkaliSensitiveLesionstoTotalDNA ModificationInducedbyBenso(a)pyrenediolepoxide. J.Biol.Chem.1984. 259: 11098-11102.

70.SodroskiJG,RosenC,HaseltineWA. Trans-actingTranscriptionalActivationofthe LongTerminalRepeatofHumanTLymphotropicVirusesinInfectedCells. Science. 1984. 225:381385.

71.HaseltineWA,SodroskiJG,PatarcaR,BriggsD,PerkinsD,Wong-StaalF. Structureof the3'TerminalRegionofTypeIIHumanTLymphotropicVirus:EvidenceforaNew CodingRegion. Science.1984. 225:419-421.

72.SodroskiJG,PatarcaR,PerkinsD,BriggsD,LeeTH,EssexM,ColiganJ,WongStaalF, GalloR,HaseltineWA. TheSequenceoftheEnvelopeGlycoproteinGeneofTypeII HumanTLymphotropicVirus. Science.1984. 225:421-424.

73.Royer-PokoraB,HaseltineWA. IsolationofUVResistantRevertantsfromaXeroderma PigmentosumComplementationGroupACellLine. Nature.1984. 311:390-392.

74.LeeTH,ColiganJE,SodroskiJG,HaseltineWA,SalahuddinSZ,Wong-StaalF,Gallo RC,EssexM. AntigensEncodedbythe3'-TerminalRegionofHumanT-CellLeukemia Virus:EvidenceforaFunctionalGene. Science.1984. 226:57-61.

75.PatarcaR,HaseltineWA. SequenceSimilarityAmongRetroviruses. Nature.1984. 309: 728.

76.PatarcaR,HaseltineWA. SimilaritiesAmongRetrovirusProteins.Nature.1984. 312: 496.

77.CelanderD,HaseltineWA. TissueSpecificPreferenceasaDeterminantofCellTropism andLeukemogenicPotentialofMurineRetroviruses.Nature.1984. 312:159-162.

78.JosephsJF,WongStaalF,ManzariV,GalloRC,SodroskiJG,TrusM,PerkinsD,Patarca R,HaseltineWA.LongTerminalRepeatStructureofanAmericanIsolateofHumanT CellLeukemiaVirus. J.Virology. 1984. 139:340-345.

79.SodroskiJG,RosenCR,Wong-StaalF,PopovicM,AryaS,GalloRC,HaseltineWA. Trans-actingTranscriptionalActivationoftheLong TerminalRepeatofHumanTCell LeukemiaVirusTypeIII(HTLV-III). Science. 1985. 227:171-173

80.RosenCA,SodroskiJG,KettmanR,BurnyA,HaseltineWA. Trans-activationofthe BovineLeukemiaVirusLongTerminalRepeat. Science.1985. 227:320-322.

81.GohWC,SodroskiJG,RosenCR,EssexM,HaseltineWA. SubcellularLocalizationof theProductoftheLongOpenReadingFrameofHumanT-CellLeukemiaVirusTypeI. Science. 1985. 227:1227-1228.

82.RatnerL,HaseltineWA,PatarcaR,LivakKJ,StarcichB,JosephsSF,DoranER,Antoni RafalskiJ,WhitehornEA,BaumeisterK,IvanoffL,PettewaySR,PearsonML, LautenbergerJA,PapasTS,GhrayebJ,ChangNT,GalloRC,Wong-StaalF. Complete NucleotideSequenceoftheAIDSVirus,HTLV-III.Nature. 1985. 313:277-284.

83.SodroskiJG,RosenCR,GohWC,HaseltineWA. TheHumanT-CellLeukemiaVirus xlorRegionEncodesaTranscriptionalActivatorProtein.Science.1985. 228: 1430-1434.

84.DoetschPW,ChanGL,HaseltineWA.T4DNAPolymerase(3'5')Exonuclease,An EnzymefortheDetectionandQuantitationofStableDNALesions: TheUltraviolet LightExample. NucleicAcidsRes. 1985. 13:3285-3304.

85.SodroskiJG,PatarcaR,RosenCR,Wong-StaalF,HaseltineWA. Locationofthe Trans-activatingRegionontheGenomeofHumanT-CellLymphotropicVirusTypeIII. Science. 1985. 229:74-77.

86.ChanGL,DoetschPW,HaseltineWA. CyclobutanePyrimidineDimers(6-4)Photo ProductBlockPolymerizationbyDNAPolymerase.Biochem. 1985. 24:5723-5728.

87.UmlasME,FranklinWA,ChanGL,HaseltineWA. UltravioletLightIrradiationof Defined-SequencedDNAUnderConditionsofChemicalPhotosensitization.Photochem Photobi.1985. 42:265-273.

88.RosenCA,SodroskiJG,HaseltineWA. LocationofCis-ActingRegulatorySequencesin theHumanTCellLeukemiaVirusTypeILongTerminalRepeat. Proc.Natl.Acad.Sci. 1985. 82:6502-6506.

89.BrashDE,HaseltineWA. PhotoreactivationofE.coliReversesumuCInductionby UltravioletLight.JBacteriology. 1985. 163:460-463

90.BrashDE,FranklinWA,SancarGB,SancarA,HaseltineWA. E.coliDNAPhotolyase ReversesCyclobutanePyrimidineDimersbutnotPyrimidine-Pyrimidone(6-4) Photoproducts. J.Biol. Chem. 1985. 260:11438-11441.

91.GohWC,SodroskiJG,RosenCR,HaseltineWA. Expressionofthex-lorGeneinE.coli. J.Virology. 1985. 55:497-499.

92.SodroskiJG,GohWC,RosenCR,SalahuddinSZ,AldoviniA,FranchiniG,Wong-Staal F,GalloRC,SugamuraK,HaseltineWA. TransactivationoftheHumanTCell LeukemiaVirusLongTerminalRepeatCorrelateswithExpressionofthex-lorProtein. J. Virology. 1985. 55:831-835.

93.RosenCR,HaseltineWA,LenzJ,RuprechtR,CloydM. TissueSelectivityofMurine LeukemiaVirus(MULV)InfectionisDeterminedbyLTRSequences. J.Virology. 1985. 55:862-866.

94.AllenJ,LeeTH,McLaneMF,SodroskiJ,HaseltineWA,EssexM. MajorGlycoprotein AntigensthatinduceAntibodiesinAIDSpatientsareencodedbyHTLVIII. Science. 1985. 228:1091-1094.

95.RosenCR,Sodroski,JG,HaseltineWA. LocationofCis-ActingRegulatorySequences intheHumanTCellLymphotropicVirusTypeIII(HTLV-III/LAV)LongTerminal Repeat. Cell. 1985. 41:813-823.

96.FranklinW,DoetschP,HaseltineWA. StructuralDeterminationoftheUltraviolet LightInducedThymine-CytosinePyrimidine-Pyrimidone(6-4)Photoproduct.Nucleic AcidsRes. 1985. 13:5317-5325.

97.RatnerL,StarcichB,JosephsSF,HahnBH,ReddyEP,LivakKJ,PettewaySR,Pearson ML,HaseltineWA,AryaSK,Wong-StaalF.Polymorphismofthe3'OpenReading FrameoftheVirusAssociatedwiththeAcquiredImmunodeficiencySyndrome,Human T-LymphotropicVirusTypeIII. NucleicAcidsRes. 1985. 13:8219-8229.

98.FreiE,CucchiC,BernalS,RheinwaldJ,HaseltineWA,ErvinT. AlkylatingAgent Resistance:InVitroStudieswithHumanNeoplasticCellLines. Proc.Natl.Acad.Sci. 1985. 82:2158-2162.

99.RosenCR,SodroskiJG,CampbellK,HaseltineWA. ConstructionofRecombinant RetrovirusesthatExpresstheHumanTCellLeukemiaVirusTypeIIandHumanTCell LeukemiaVirusTypeIIITransactivator. J.Virology.1986. 57:379-384.

100. RuprechtRM,RossoniLD,HaseltineWA,BroderS. SupressionofRetroviral PropagationandDiseasebySuramininMurineSystems. Proc.Natl.Acad.Sci.1985. 82:77337737.

101. JanicekMF,HaseltineWA,HennerWD. MalondialdehydePrecursorsin gammairradiatedDNA,deoxynucleotidesanddeoxynucleosides. NucleicAcids Research. 1985. 13:9011-9029.

102. PatarcaR,HaseltineWA. AMajorRetroviralCoreProteinRelatedtoEPAand TIMP. Nature. 1985. 318:390.

103. FranklinWA,HaseltineWA. TheRoleofthe(6-4)PhotoproductinUltraviolet LightInducedTransitionMutationsinE.coli. MutationResearch. 1986. 165:1-7.

104. RosenCA,SodroskiJG,GohWC,DaytonA,LippkeJ,HaseltineWA. Post TranscriptionalRegulationAccountsforthetrans-activationoftheHumanT LymphotropicVirusesTypeIII(HTLV-III/LAV). Nature. 1986. 319:555-559.

105. RosenCR,SodroskiJG,HaseltineWA. ActivationofEnhancerSequencesinthe TypeIIHumanTCellLeukemiaVirusandBovineLeukemiaVirusLongTerminal RepeatsbyViralAssociatedTransactingRegulatoryFactors. J.Virology. 1986. 57: 738-744.

106. SodroskiJG,GohWC,RosenCA,TartarA,PortetelleD,BurnyA,HaseltineWA. ReplicativeandCytopathicPotentialofHumanTLymphotropicVirusTypeIII (HTLVIII/LAV)withsorGeneDeletion. Science. 1986. 231:1549-1553.

107. DaytonAI,SodroskiJG,GohWC,HaseltineWA. TheTrans-activatorGeneofthe HumanT-CellLymphotropicVirusTypeIIIisrequiredforReplication. Cell. 1986. 44: 941947.

108. DoetschPW,HellandD,HaseltineWA.MechanismofActionofaMammalianDNA RepairsEndonuclease. Biochem. 1986. 25:2212-2220.

109. ElfassiE,HaseltineWA,DienstagJL.DetectionofHBV-XProductUsinganopen ReadingFrameEscherichiacoliExpressionVector. Proc.Natl.Acad.Sci. 1986. 83: 22192222.

110. GreeneWC,LeonardWJ,WanoJ,SvetlikPB,PefferNJ,SodroskiJG,RosenCA, GohWC,HaseltineWA. TheTransactivatorGeneofHumanTLymphotropicVirus TypeII(HTLVII)InducesInterleukin-2ReceptorandInterleukin-2GeneExpression. Science. 1986. 232: 877-880.

111. ChanGL,PeakMJ,PeakJG,Haseltine,WA. ActionSpectrumfortheFormationof Endonuclease-sensitivesitesand(6-4)PhotoproductsInducedinaDNAbyUltraviolet Radiation. J.RadiationBiol.1986. 50:641-648.

112. GohWC,RosenCA,SodroskiJG,HoDD,HaseltineWA. IdentificationofaProtein EncodedbytheTransactivatorGene,tatIII,ofaHumanT-CellLymphotropicRetrovirus TypeIII. J.Virology. 1986. 59:181-184.

113. HellandD,DoetschPW,HaseltineWA. SubstrateSpecificityofaMammalianDNA RepairEndonucleasethatRecognizesOxidativeBaseDamage. Mol.CellBiol. 1986. 6: 19831990.

114. SodroskiJG,GohWC,RosenCA,DaytonAI,TerwilligerE,HaseltineWA. A Secondpost-TranscriptionalTrans-activatorGenerequiredforHTLVIIIReplication. Nature. 1986. 321:412-417.

115. SutherlandBM,FengNI,OlivieraOM,CairrachiG,BrashDE,HaseltineWA,Lewis RJ,HanawaltPC. SubstrateRangeofthe40000-DaltonDNA-Photoreactivating EnzymefromEscherichiacoli. Biochem. 1986. 25:681-687.

116. Sodroski,JG,GohWC,RosenCA,CampbellK,HaseltineWA. Roleofthe HTLVIII/LAVEnvelopeinSyncytiumFormationandCytopathicity. Nature.1986. 322: 470-474.

117. TaneseN,SodroskiG,HaseltineWA,GoffSP. ExpressionofReverseTranscriptase ActivityofHumanT-LymphotropicVirusTypeIII(HTLV-III/LAV)inEscherichiacoli. J.Virology. 1986. 59:743-745.

118. RosenCA,SodroskiJG,WillemsL,KettmannR,CampbellK,ZayaR,BurnyA, HaseltineWA. The3'regionofbovineleukemiavirusgenomeencodesatrans-activator protein. EMBOJournal. 1986. 10:2585-2589.

119. HaseltineWA,PatarcaR. PresenceintheAIDSVirusofSequencesSimilartothe Scrapie-RelatedPrP27-30Protein. Nature. 1986. 323:115-116.

120. ElfassiE,PatarcaR,HaseltineWA. Similaritiesamongthepre-SRegions of HepatitisVirusesAnalogywithRetroviralTransmembraneProteins. J. Theoretical Biology. 1986. 121:371

121. PatarcaR,HaseltineWA. VariationAmongtheHumanT-CellLymphotropicVirus TypeIII(HTLV-III/LAV)Strains. JournalofTheoreticalBiology. 1986.

122. TerwilligerE,SodroskiJG,RosenCA,HaseltineWA. EffectsofMutations Within the3'-ORFRegionoftheHTLV-III/LAVonReplicationandCytopathicity. Journalof Virology. 1986. 60:754-760.

123. GohWC,SodroskiJG,RosenCA,HaseltineWA. ExpressionoftheartGeneProtein ofHTLV-III/LAVinBacteria. J.Virology. 1987. 61:633-637.

124. PatarcaR,HaseltineWA.HIVtatandtar. AIDSResearchandHumanRetroviruses. 1987. 3:1-2.

125. PatarcaR,HeathC,GoldenbergG,RosenCA,SodroskiJG,HaseltineWA,Hansen U. TranscriptionDirectedbytheHIVLongTerminalRepeatInVitro. AIDSResearch andHumanRetroviruses. 1987. 3:41-55.

126. MoscaJD,BednarikDP,RajNBK,RosenCA,SodroskiJG,HaseltineWA,PithaPM. Herpessimplexvirustype-1canreactivatetranscriptionoflatenthuman immunodeficiencyvirus. Nature. 1987. 325:67-70.

127. RosenCA,ParkR,SodroskiJG,HaseltineWA. Multiplesequenceelementsare requiredforregulationofhumanT-cellleukemiavirusgeneexpression. Proc.Natl. Acad.Sci. 1987. 84:4919-4923.

128. CelanderDandHaseltineWA. GlucocorticoidRegulationofMurineLeukemiaVirus TranscriptionElementsIsSpecifiedbyDeterminantswithintheViralEnhancerregion. JournalofVirology. 1987. 61:266-275.

129. WalkerBD,KowalskiM,GohWC,RohrschneiderL,HaseltineWA,SodroskiJG. InhibitionofHumanImmunodeficiencyVirusSyncytiumFormationand Replicationby Castanospermine. Proc.Natl.Acad.Sci. 1987. 84:8120-8124

130. KowalskiM,PotzJ,BasiripourL,DorfmanT,GohWC,TerwilligerE,Dayton A, RosenC,HaseltineWA,SodroskiJ. FunctionalRegionsoftheHuman ImmunodeficiencyVirusEnvelopeGlycoprotein. Science. 1987. 237:1351.

131. MoscaJD,BednarikDP,RajNBK,RosenCA,SodroskiJG,HaseltineWA,Hayward GS,PithaPM. Activationofhumanimmunodeficiencyvirusbyherpesvirusinfection:

Identificationofaregionwithinthelongterminalrepeatthatrespondstoatrans-acting factorencodedbyherpessimplexvirus1. Proc.Natl.Acad.Sci. 1987. 84:7408-7412.

132. TerwilligerE,BurghoffR,SiaR,SodroskiJG,HaseltineW,RosenC. TheartGene ProductoftheHumanImmunodeficiencyVirusisRequiredforReplication. Journalof Virology. 1988. 62:655-658.

133. RosenCA,TerwilligerE,SodroskiJG,HaseltineWA.Intrageniccisactingart ResponsiveSequencesoftheHumanImmunodeficiencyVirus. Proc.Natl.Acad.Sci. 1988. 85:2071-2075

134. CelanderD,HsuBL,HaseltineWA. RegulatoryElementswithintheMurine LeukemiaVirusEnhancerRegionsMediateGlucocorticoidResponsiveness. Journalof Virology. 1988. 62:1314-1322.

135. RubenS,PoteatH,TanTse-Hau,KawakamiK,RoederR,HaseltineW,RosenC. IdentificationofCellularTranscriptionFactorsRequiredForRegulationofInterleukin2 ReceptorGeneExpressionBytheHumanT-CellLeukemiaVirustatGeneProduct. Science. 1988. 241:89-92.

136. ParkRE,HaseltineWA,RosenCA. ANuclearFactorMediatesTransactivationof HTLV-IGeneExpression.Oncogene. 1988. 3:275-279.

137. CohenEA,TerwilligerEF,SodroskiJG,HaseltineWA.Identificationofaprotein encodedbythevpugeneofHIV-1. Nature. 1988. 334:532-534.

138. TerwilligerEF,GodinB,SodroskiJG,HaseltineWA. ConstructionandUseofa Replication-CompetentHumanImmunodeficiencyVirus(HIV-1)thatExpressestheCAT EnzymeMarkedViruses/ReplicationStudies/DrugScreening. Proc.Natl.Acad.Sci. 1989. 86:3857-3861

139. ParkinNT,CohenEA,DarveauA,RosenCA,HaseltineA,SonenbergN. TranslationalEffectsofthe5'Non-CodingRegionofHumanImmunodeficiencyVirus Type-1. EmboJournal. 1988. 7:2831-2837.

140. TerwilligerEF,ProulxJ,SodroskiJG,HaseltineWA. CellLinesThatExpressStably envGeneProductsfromThreeStrainsofHIV-1. JournalofAcquiredImmune DeficiencySyndromes. 1988. 1:317-323.

141. DaytonAI,TerwilligerEF,PotzJ,KowalskiMM,SodroskiJG,HaseltineWA. CisActingSequencesResponsivetotherevGeneProductoftheHuman ImmunodeficiencyVirus. JournalofAcquiredImmuneDeficiencySyndromes. 1988. 1: 441-452.

142. GrassmannR,DenglerC,Muller-FleckensteinI,FleckensteinB,McGuireK, DokhelarM,SodroskiJG,HaseltineWA. TransformationtoContinuousGrowthof PrimaryHumanLymphocytesbyHTLV-1XRegionGenesTransducedbyaHerpesvirus SaimiriVector. Proc.Natl.Acad.Sci. 1989. 86:3351-3355.

143. KozarskyK,PenmanM,BasiripourL,HaseltineWA,SodroskiJG,KriegerM. GlycosylationandProcessingoftheHumanImmunodeficiencyVirusType1Envelope. JournalofAcquiredImmuneDeficiencySyndromes. 1989. 2:163-169.144. Poteat H,KadisonP,McGuireK,ParkL,ParkRE,SodroskiJG,HaseltineWA. TheResponse oftheHTLV-1LTRtoCyclicAMP. JournalofVirology. 1989. 63:1604-1611.

144. KowalskiMM,ArdmanB,BasiripourL,LuY,BlohmD,HaseltineWA,Sodroski JG. AntibodiesToCD4inHIV-1-InfectedIndividuals. Proc.Natl.Acad.Sci. 1989. 86: 33463350.

145. DokhelarMC,PickfordH,SodroskiJG,HaseltineWA. HTLV-1p27rex Regulatesgag andenvProteinExpression. JournalofAcquiredImmuneDeficiencySyndromes. 1989. 2:431-440.

146. GottlingerHG,SodroskiJG,HaseltineWA. RoleofcapsidPrecursorProcessing MyristylationinHIV-1MorphogenesisandInfectivity. Proc.Natl.Acad.Sci. 1989. 86:57815785.

147. LeverA,GottlingerHG,HaseltineWA,SodroskiJG. IdentificationofaSequence RequiredforEfficientPackagingofHIV-1RNAintoVirions. JournalofVirology. 1989. 63:4085-4087.

148. TerwilligerEF,CohenEA,LuY,SodroskiJG,HaseltineWA. FunctionalRoleof HIV1vpu. Proc.Natl.Acad.Sci. 1989. 86:5163-5167.

149. DokhelarMC,PickfordH,SodroskiJG,HaseltineWA. ThePotentialfor HomeostaticregulationoftheXRegionProteinsoftheHumanTCellLeukemiaVirus TypeI. JournalofAcquiredImmuneDeficiencySyndromes. 1989. 2:588-594.

150. TwuJS,RosenCA,HaseltineWA,RobinsonWS. IdentificationofaRegionwithin theHumanImmunodeficiencyVirusType1LongTerminalRepeatThatIsEssentialfor TransactivationbytheHepatitisBVirusGeneX. Journalof Virology. 1989. 63: 2857-2860.

151. LuY,StenzelM,SodroskiJG,HaseltineWA. EffectsofLTRMutantsonHIV-1 Replication. JournalofVirology. 1989. 63:4115-4117.

152. CohenEA,TerwilligerEF,JalinoosY,ProulxJ,SodroskiJG,HaseltineWA. IdentificationofHIV-1vprProductStructureandFunction.JournalofAcquiredImmune DeficiencySyndromes. 1990. 3:11-18.

153. CaputoA,SodroskiJG,HaseltineWA.ConstitutiveExpressionofHIV-1tatProtein inHumanJurkatTCellsUsingaBKVirusVector.JournalofAcquiredDeficiency Sydromes.1990.3:373-379.

154. SalfeldJ,GottlingerHG,SiaR,ParkR,SodroskiJG,HaseltineWA.ATripartite HIV1tat-env-revFusionProtein.EMBO.1990.9:965-970.

155. PoteatH,ChenF,KadisonP,SodroskiJ.HaseltineW.ProteinKinaseADependent BindingofaNuclearFactortothe21BasePairRepeatoftheHumanTCellLeukemia VirusType1LongTerminalRepeat.JournalofVirology.1990.1264-1270.

156. RosenC,CampbellK,GodinB,SodroskiJ,HaseltineW. SubcellularLocalizationof HumanImmunodeficiencyVirus(HIV)RegulatoryProteins,tatandart. Journalof Virology. 1988. 62: 2498-2501.

157. ArdmanB,KowalskiM,BristolJ,HaseltineW,SodroskiJ. EffectsonCD4Binding ofAnti-peptideSeratotheFourthandFifthConservedDomainsofHIV-1gp120. JournalofAcquiredImmuneDeficiencySyndrome. 1990. 3:206-214.

158. HelsethE,Kowalski,GabuzdaD,OlshevskyU,HaseltineWA,SodroskiJG. Rapid ComplementationAssaysmeasuringreplicativepotentialofHIV-1envelopeglycoprotein mutants. JournalofVirology. 1990. 64:2416-2420.

159. CohenE,DehniG,SodroskiJ,HaseltineW. HumanImmundeficiencyVirusvpr ProductisaVirion-AssociatedRegulatoryProtein.JournalofVirology. 1990. 64: 3097-3099.

160. CohenE,LuY,GottlingerH,DehniG,SodroskiJ,HaseltineW.TheTOpenReading FrameofHumanImmunodeficiencyVirusType1.1990. JournalAcquiredImmune DeficiencySyndrome.Vol3.6: 601-608.

161. FarnetC,HaseltineWA. IntegrationofHIV-1DNAinvitro. 1990. Proc.Natl. Acad.Sci. 87:4164-4168.

162. ZazopoulosE,SodroskiJG,HaseltineWA. p21rex proteinofHTLV-1. 1990. Journal ofAcquiredImmuneDeficiencySyndrome. 3:121135-1139.

163. LuY,TouzjianN,StenzelM,DorfmanT,SodroskiJ,HaseltineWA. Identificationof cis-actingrepressivesequenceswithintheNegativeRegulatoryElementofHIV-1.1990. JournalofVirology. 1990. 64:5226-5229.

164. OlshevskyU,HelsethE,FurmanC,LiJ,HaseltineWA,SodroskiJG. Identification ofIndividualHIV-1gp120AminoAcidsImportantforCD4ReceptorBinding. Journal ofVirology. 1990. 65:5701-5707.

165. GabuzdaD,OlshevskyU,BertaniP,HaseltineW,SodroskiJ. Identificationof MembraneAnchorageDomainsoftheHIV-1gp160EnvelopeGlycoproteinPrecursor. JournalofAcquiredImmuneDeficiencySyndrome.1991. Volume4. 1:34-40.

166. LuY,TouzjianN,DorfmanT,SodroskiJ,HaseltineW. TheNFkBindependent cisactingsequencesinHIV-1LTRresponsivetoT-cellactivation. JournalofAcquired ImmuneDeficiencySyndrome. 1991. Volume4. 2:173-177.

167. PrasadV,MyrickK,HaseltineW,GoffS. ExpressionofEnzymaticallyActive ReverseTranscriptaseofSimianImmunodeficiencyVirusinBacteria: Sensitivityto NucleotideAnalogueInhibitors. 1990.JournalofVirology. 179: 896-900.

168. GottlingerH,DorfmanT,SodroskiJ,HaseltineW. EffectofMutationsAffectingthe P6gagProteinonHIV-1ParticleRelease. Proc.Nat'lAcad.Sci. 1991. 88:3195-3199.

169. FarnetC,HaseltineW. Determinationofviralproteinspresentinthe HIV-preintegrationcomplex. JournalofVirology. 1990.65(4):1910-1915.

170. PoznanskyM,WalkerB,HaseltineW,SodroskiJ,LanghoffE. ARapidfor QuantitatingtheFrequencyofPeripheralBloodCellsContainingHIV-1DNA. Journal ofAcquiredImmuneDeficiencySyndrome. 1991. 4:368-373.

171. LetvinNL,LordCI,KingNW,WyandMS,MyrickKV,HaseltineWA. Infectionof MacaqueMonkeybySIVProviralDNA. 1991. Nature.

172. HelsethE,OlshevskyU,GabuzdaD,ArdmanB,HaseltineWA,SodroskiJG. ChangesintheTransmembraneRegionoftheHIV-1gp41EnvelopeGlycoproteinAffect MembraneFusion. JournalofVirology. 1990. 64:5764-5772.

173. PoznanskyM,LeverA,BergeronL,HaseltineW,SodroskiJ. GeneTransferinto HumanLymphocytesbyaDefectiveHumanImmunodeficiencyVirusType1Vector. JournalofVirology. 1991.65:532-536.

174. KallandK,LanghoffE,BosH,GottlingerH,HaseltineW. Rexdependentnucleolar concentrationofHTLV-1envmRNA. TheNewBiologist.1991. 3:389-397.

175. AmerongenH,WeltzinR,FarnetC,MichettiP,HaseltineW,NeutraM. TransepithelialtransportofHIV-1byintestinalMcells: amechanismfortransmissionof AIDS.1991. JournalofAcquiredImmuneDeficiencySyndrome.1991. 4:760-765.

176. KowalskiM,BergeronL,DorfmanT,HaseltineW,SodroskiJ. Attenuationof HumanImmunodeficiencyVirusTypeI(HIV-1)CytopathicEffectbyaMutation AffectingtheTransmembraneEnvelopeGlycoprotein. 1991.JournalofVirology. 65: 281-291.

177. HellandDE,WellesJL,CaputoA,HaseltineWA. TranscellularTransactivationby theHIV-1tatprotein.1991. JournalofVirology.65:4547-4549

178. FazelyF,HaseltineWA,RodgerRF,andRuprechtRM. Post-exposure ChemoprophylaxiswithAZTorAZTCombinedwithInterferon-":Failureafter inoculatingRhesusMonkeyswithaHighDoseofSIV. JournalofAcquiredImmune DeficiencySyndrome. 1991. 4:1093-1097.

179. LanghoffE,TerwilligerE,BosH,KallandK,PoznanskyM,SodroskiJ,HaseltineW. ProlificReplicationofHIV-1inPrimaryDendriticCellCultures. 1991. Proc.Natl. Acad.Sci. 88:7998-8002.

180. TerwilligerE,LanghoffE,GabuzdaD,HaseltineW. Allelicvariationintheeffects ofnefonHIV-1replication. Proc.Natl.Acad.Sci.1991.88:10971-10975.

181. FarnetC,HaseltineWA. Circularizationofhumanimmunodeficiencyvirustype1 (HIV1)DNAinvitro. JournalofVirology. 1991. 65(12):6942-6952.

182. ObaruK,DeClueJandHaseltineWA. Anaminoterminalaminoacidaffectsthe electrophoreticmobilityoftheHIV-1nefprotein. JournalofAcquiredImmune DeficiencySyndromes.1991.5:308-312.

183. CaputoandHaseltine. Re-examinationofthecodingpotentialoftheHTLV-1pX region. Virology.1992.Vol.188,No.2,pp.618-627.

184. MerkleR,HellandD,WellesJ,ShilatifardA,HaseltineW,CummingsR. GP160of HIV-1synthesizedbypersistentlyinfectedmolt-3cellsisterminallyglycosylated: evidencethatcleavageofgp160occurssubsequenttooligosaccharideprocessing. ArchivesofBiochemistryandBiophysics. 1991. Vol.290,No.1,pp.248-257.

185. GottlingerH,DorfmanT,CohenE,HaseltineW. Theroleofthetnvproteinandtnv RNAsplicingsignalsinreplicationofHIV-1IIIBisolates. Virology1992.189:618-628.

186. Zazopoulos,E.,Haseltine,W. MutationalanalysisoftheHIVElineffunction. Proc. Nat.Acad.Sci.USA. 1992.88:6634-6638.

187. LiJ,LordCI,HaseltineWA,LetvinNL,SodroskiJG. InfectionofCynomolgus MonkeyswithaChimericHIV-1/SIVmac VirusthatExpressestheHIV-1Envelope Glycoproteins. JournalofAcquiredImmuneDeficiencySyndromes.1992.5:639-646.

188. MarascoWA,BagleyJ,ZaniC,PosnerM,CavaciniL,HaseltineWA,SodroskiJG. Characterizationofthe cDNAofaBroadlyReactiveNeutralizingHumanAnti-gp120 MonoclonalAntibody. J.ClinicalInvestigation. 1992.J.ClinicalInvestigation. 1992;90:14671478.

189. GrassmannR,BerchtoldS,RadantI,AltM,FleckensteinB,SodroskiJG,Haseltine WA,RamstedtHU. RoleofHumanT-CellLeukemiaVirusType1XRegionProteinsin ImmortalizationofPrimaryHumanLymphocytesinCulture. JournalofVirology.1992. Vol.66,No.7,pp.4570-4575.

190. LoKMS,BiasoloMA,DenhiG,PaluG,Haseltine,WA. InhibitionofReplicationof HIV-1byRetroviralVectorsExpressingtat-AntisenseandAnti-tatRibozymeRNA. Virology.1992.Vol.190,No.1,pp.176-183.

191. GabuzdaDH,LawrenceK,LanghoffE,TerwilligerEF,DorfmanT,HaseltineWA, SodroskiJG. TheRoleofvifinReplicationofHIV-1inCD4+TLymphocytes. J. Virology. 1992.66:6489-6494.

192. RepkeH,GabuzdaD,EmmrichF,PaluG,SodroskiJ,HaseltineW. Effectsof syntheticpeptidesfromCD4onfunctionofhumanretroviralenvelopeglycoprotein. J. Immunology. 1992.149:1809-1816.

193. RepkeH,BarberE,UlbrichtS,BuchnerK,HuchoF,KoppR,ScholzH,RuddC, HaseltineWA. Ganglioside-inducedCD4EndocytosisOccursIndependentofSerine PhosphorylationandisAccompaniedbyDissociationofp56LCK . J.Immunology. 1992. 149:2585-2591.

194. YaoX-J,GottlingerH,HaseltineWAandCohenEA. EnvelopeGlycoproteinand CD4Independenceofvpu-FacilitatedHumanImmunodeficiencyVirusType1Capsid Export. J.Virology.1992. 66:5119-5126.

195. Zazopoulos,EandHaseltineWA. DisulfideformationoftheHIV-1nefprotein. J. Virology,1993.67:1676-1680.

196. Überla,K,LuY,ChungE,andHaseltineWA. CharacterizationoftheNF-kappaB p65promotor. J.Acquir.Immun.Def.Synd.1993.6:227-230.

197. Zazopoulos,EandHaseltineWA. Effectofnefallellesonreplicationofhuman immunodeficiencyvirustype1. J.Virology. 1992.194:20-27

198. YaoX-J,GarzonS,BoisvertF,HaseltineWH,andCohenE. Theeffectofvpuon HIV-1InducedSyncytiaFormation.J.Acquir.Immun.Def.Synd.1993.6:135-141.

199. ShilatifardA,MerkleRK,HellandDE,WellesJL,HaseltineWAandCummingsRD. Complex-typeN-LinkedOligosaccharidesofgp120fromHumanImmunodeficiency VirusType1ContainSulfatedN-Acetylglucosamine. J.Virology.1993.67:943-952.

200. LanghoffE,KallandKH,andHaseltineWH. Earlymolecularreplicationofhuman immunodeficiencyvirustype1inculturedbloodderivedThelperdendriticcells. J.Clin. Inves.1993.91:2721-2726.

201. Göttlinger,H.G.,Dorfman,T.,Cohen,E.A.,andHaseltine,W.A.Vpuproteinof humanimmunodeficiencyvirustype1enhancesthereleaseofcapsidsproducedby gag geneconstructsofwidelydivergentretroviruses.Proc.Natl.Acad.Sci.USA1993. 90:7381-7385.

202. McGuireK,CurtissVS,LarsonEL,HaseltineWA. InfluenceofhumanT-cell leukemiavirustype1taxandrexoninterleukin-2geneexpression. J.Virol.1993. 67:1590-1599.204. MarascoWA,HaseltineWA,andChenSY.Design,Intracellular Expression,andActivityofaHumanAnti-HIV-1gp120SingleChainAntibody.Proc. Natl.Acad.Sci.U.S.A.,90:7889-7893,1993.

203. Dorfman,T.,Luban,J.,Goff,S.P.,Haseltine,W.A.,andGöttlinger,H.G.Mappingof functionallyimportantresiduesofacysteine-histidineboxinthehuman immunodeficiencyvirustype1nucleocapsidprotein.J.Virol.1993.67:6159-6169.

204. N.Papadopoulos,N.C.Nicolaides,Ying-FeiWei,S.M.Ruben,K.C.Carter,C.A. Rosen,W.A.Haseltine,R.D.Fleischmann,C.M.Fraser,M.D.Adams,J.C.Venter,S.

R.Hamilton,G.M.Petersen,P.Watson,H.T.Lynch,P. Peltomaki,Jukka-Pekka Mecklin,A.delaChapelle,K.W.Kinzler,B.Vogelstein. Mutationofa mutLHomolog inHereditaryColonCancer.Science 1994. Vol.263;pp1625-

205. N.Papadopoulos,N.C.Nicolaides,Ying-FeiWei,S.M.Ruben,K.C.Carter,C.A. Rosen,W.A.Haseltine,R.D.Fleischmann,C.M.Fraser,M.D.Adams,J.C.Venter,S. R.Hamilton,G.M.Petersen,P.Watson,H.T.Lynch,P. Peltomaki,Jukka-Pekka Mecklin,A.delaChapelle,K.W.Kinzler,B.Vogelstein. MutationsofTwo mutL Homologs, hPMS1 and hPMS2,inHereditaryNonpolyposisColonCancer

206. Wei,Y.F.,Robins,P.,Carter,K.,Caldecott,K.,Pappin,D.J.C.,Haseltine,W.A., Lindahl,T. MolecularCloningandExpressionofHumancDNAsEncodingaNovel DNALigaseIVandDNALigaseIII,anEnzymeActiveinDNARepairand Recombination. MolecularandCellularBiology.June1995.Vol.15,No.6,pp. 3206-3216.

207. Uberla,K.,Stahl-Hennig,C.,Bottiger,D.,Matz-Rensing,K.,Kaup,F.J.,Li,J., Haseltine,W.A.,Fleckenstein,B.,Hunsmann,G.,Oberg,B.,SodroskiJ. Animalmodel forthetherapyofacquiredimmunodeficiencysyndromewithreversetranscriptase inhibitors. Proc.Natl.Acad.Sci.USA. August1995. Vol.92,pp.8210-8214.

208. Wei,Y.F.,Robins,P.,Carter,K.,Pappin,D.J.C.,Wang,R.P.,Shell,B.K.Schar,Primo, S.,Nash,R.,Cadecott,K.,Barnes,D.E.,Haseltine,W.A.,Lindahl,T. Molecularcloning andexpressionofthehumancDNAe3ncodingDNAligaseIII,anenzymeactiveinDNA repairandrecombination. JournalofBiologicalChemistry. November29,1996. Vol. 271,No.48,pp.30375-30380.

209. Haseltine,W.A.DiscoveringGenesforNewMedicines. ScientificAmerican. March1997. Vol.276,No.3,pp.92-97.

210. Haseltine,W.A.ThePowerofGenomicstotransformthebiotechnologyindustry. NatureBiotechnology. May1998.Supplement.pp.25-27.

211. Friborg,J.,Ladha,A.,Göttlinger,H.,Kalland,K.,Haseltine,W.A.,andCohen,E.A. Functionalanalysisofthephosphorylationsitesonthehumanimmunodeficiencyvirus type1Vpuprotein.JournalofAcquiredImmuneDeficiencySyndromes,January1, 1995.Vol8.pp.10-22

212. Lavallée,C.,Yao,X.J.,Ladha,A.,Göttlinger,H.,Haseltine,W.A.,andCohen,E.A. RequirementofPr55gag precursorfortheincorporationoftheVprproductintohuman immunodeficiencyvirustype1viralparticles.JournalofVirology March1994. Vol.3. pp.1926-1934.

213. Dorfman,T.,Mammano,F.,Haseltine,W.A.,andGöttlinger,H.G.Roleofthep17 matrixproteininthevirionassociationofthehumanimmunodeficiencyvirustype1 envelopeglycoprotein. JournalofVirology,March1994.Vol.3.pp.1689-1996.

214. Patarca,Roberto.,Haseltine,W.A.StructuralflexibilityoftheSARS-CoV-2genome relevanttovariation,replication,pathogenicity,andimmuneevasion.BioRxiv.December 20,2021.DOI:https://doi.org/10.1101/2021.12.20.473542

215. Patarca,Roberto.,Haseltine,W.A.Circularizationviacomplementarysequencesin the5'and3'terminimayfacilitatereplicationofSARScoronaviruses.Authorea.January 04,2022.DOI:10.22541/au.164132044.46753705/v1

216. Patarca,Roberto.,Haseltine,W.A.IntragenomicrearrangementsofSARS-CoV-2and otherβ-coronaviruses.BioRxiv.March3,2022.DOI: https://doi.org/10.1101/2022.03.07.483258

217. Patarca,Roberto.,Haseltine,W.A.,FortyyearsofHIVresearchinspiresthe developmentofSARS-CoV-2therapy, Journal of Molecular Cell Biology,2023.DOI: https://doi.org/10.1093/jmcb/mjad065

218. Patarca,Roberto.,Haseltine,W.A.,BioinformaticsInsightsonViralGeneExpression Transactivation:FromHIV-1toSARS-CoV-2, Preprints, 2024.DOI: https://10.20944/preprints202401.2016.v1

219. Haseltine,W.A.;Hazel,K.;Patarca,R.RNAStructure:Past,Future,andGene TherapyApplications.Preprints2024,2024120012. https://doi.org/10.20944/preprints202412.0012.v1

220. PatarcaR,HaseltineWA.ProteinFunctionalEffector(pfe)NoncodingRNASAre IdenticaltoFragmentsfromVariousNoncodingRNAs.InternationalJournalof MolecularSciences.2025;26(14):6870.https://doi.org/10.3390/ijms26146870

Books and Monographs

1. HaseltineWA,IN:JeffreyMiller ExperimentsinMolecularGenetics. ColdSpring Harbor,NewYork: 1972. 326-347.

2. HaseltineWA,BlockR. InVitroSynthesisofppGppandpppGpp. In:TissiersN, Normura,LengylP,eds. Ribosomes. ColdSpringHarborPress,NewYork:1973. 747-761.

3. HaseltineWA,BlockR,WeberK,GilbertW MSIandMSIIareMadeontheRibosome inandIdlingStepofProteinSynthesis. IN:ZubayG,MarmurJ,eds. Papersin BiochemicalGenetics. NewYork:Holt,Reinhart,Winston,Inc. 1973. 570.

4. BesmerP,SmotkinD,HaseltineWA,BaltimoreD. MechanismofInductionofRNA TumorVirusesbyHalogenatedPyrimidines. ColdSpringHarborLaboratoryofQuant. Bio.NewYork:1974. 1103-1107.

5. HaseltineWA,BaltimoreD. InVitroReplicationofRNATumorVirus. IN:Baltimore D,HuangA,FoxCF,eds. AnimalVirology,ICN-UCLASymposiaonMolecularand CellularBiology NewYork:AcademicPress.1976. IV:175-213.

6. HaseltineWA,KleidD,PedersenFS. AnalysisofRNATumorVirusGenomes.IN: KalterS,HellmanA,GruberJ,eds. AdvancesinComparativeLeukemiaResearch. NorthHolland:BiomedicalPress.1977. 437-442.

7. HaseltineWA,KleidD. ANewLookattheStructureofPrimateTypecViralGenomes. IN:KalterS,HellmanA,GuberJ,eds.PrimatesandHumanCancer DHEW(NIH). 1977. 185195.

8. HaseltineWA,PedersenFS,SahaganBG,RosenbergZF ComparativeAnalysisofRNA TumorVirusGenomes. IN:NethR,GalloR,eds.ModernTrendsinHumanLeukemia III,1978.

9. GrossmanL,RiazuddinS,HaseltineWA,LindanK. NucleotideExcisionRepairof DamagedDNA. ColdSpringHarborLaboratoryofQuantBiolSymp.1979. 43: 947-955.

10.HaseltineWA,CoffinJA.InVitroStudiesoftheReplicationofMoloneyMurine LeukemiaVirus. ColdSpringHarborLaboratoryofQuantBiolSymp.1979. 43: 841-849.

11. PedersenFS,HaseltineWA. AMicromethodforDetailedCharacterizationofHigh MolecularWeightRNA. IN:GrossmanL,MoldaveK,eds.MethodsinEnzymology. NewYork. AcademicPress.1980. 65.

12.HaseltineWA,LindanCP,D'AndreaAD,JohnsrudL. TheuseofDNAFragmentsof DefinedSequencefortheStudyofDNAandRepair. IN:GrossmanL,MoldaveK,eds. MethodsinEnzymology.NewYork.AcademicPress,1980. 65:235-248.

13.ClementsJE,PedersenFS,NarayanO,HaseltineWA. MutationasaMechanismfor EscapefromImmuneSuppression:theVisnaVirusExample.IN:VirusesinNaturally OccurringCancers. NewYork:ColdSpringHarborConferencesonCellProliferation. 1980. 7:953-967.

14.SahaganBG,RosenbergZR,HaseltineWA. RestrictionEnzymeAnalysisoftheFeline SarcomaVirusProvirusinMurineFibroblastsTransformedbyTransfection. IN:Hardy WDJr,Essex,McClellandAJ,eds.FelineLeukemiaVirus.NorthHolland.1980. 345-352.

15.RosenbergZF,PedersenFS,HaseltineWA.ComparativeAnalysisoftheGenomesof FelineLeukemiaViruses.IN:HardyWDJr,EssexM,McClellandAJ,eds.Feline LeukemiaVirus.NorthHolland:1980. 355-359.

16.ClementsJE,DAntoniaN,NaqrayanO,PedersenFS,HaseltineWA. Antigenic VariationofVisnaVirus.IN:FildsB,JaenischR,FoxCT,eds.AnimalVirusGenetics, ICN-UCLASymposiaonMolecularandCellularBiology.NewYork:AcademicPress. 1980. XVIII.

17.GrafstrnomR,SnaperN,GrossmanL,HaseltineWa. IncisionofPyrimidineDimer ContainingDNAbySmallMolecularWeightEnzymes.IN:SeeburgE,eds. ChromosomeDamageandRepair.PlenumPress.1980.

18.GrunbergerD,BelandFA,DippleA,HaseltineWA,PoirierMO,SingerB.Quantitation ofDNADamage. J.SupramolecularStructureandCellularBiochemistry.

19.HaseltineWA,LippkeJA,GordanLK,BrashDE. DetectionorAlkalineSensitive LesionsInducedbyUltravioletLightatPyrimidine-CytosineSequencesinDNA.IN: HarrisC,CeruttiP,eds.ProceedingsoftheICN-UCLASymposiaonMechanismsof ChemicalCarcinogenesis.1982. 2:363-449.

20.HaseltineWA,GordonLR,LindanC,LippkeJ,BrashD,LoRM,Royer-PokoraB. New ApproachestoDNADamageandRepair:TheUltravioletLightExample.IN:Lemontt JF,GenerosoWM,eds.MolecularandCellularMechanismsorMutagenesis. NewYork: PlenumPress.1982. 315-332.

21.LippkeJ,HaseltineWA. TheHumanAlphoidSequenceasanIndicatorofDNA DamageinIntactCells. IN:HanawaltlPC,FriedbergEC,eds.sDNARepair:A LaboratoryManualofResearchProcedures.NewYork:MarcelDekker,Inc.1983. 2: 187-198.

22.HaseltineWA. UltravioletLightRepairandMutagenesisRevisited. Cell. 1983. 33: 1317.

23.FranklinWA,HaseltineWA. TheUseofPost-labelingMethodstoDetectand CharacterizeInfrequentBaseModificationsinDNA. IN:HanawaltPC,FriedbergC, Eds. DNARepair:ALaboratoryManualofResearchProcedures. NewYork:Marcel Dekker,Inc. 1983. 2:161-171.

24.HaseltineWA,BrashDE,LippkeJA,BrashDE,LoKM. NewApproachestoDNA DamageandRepair. IN:RTSchimke,ed.GeneAmplification. ColdSpringHarbor. 1982. 263-272.

25.HaseltineWA,FranklinWA,LippkeJA,BrashDE,LoKM.PossibleBiological SignificanceofaNovelUltravioletLightInducedDNAPhotoproduct. IN:Perspectives onGenesandtheMolecularBiologyofCancer. Texas:RobbersonSaunders,ds.Raven Press. 1982. 291-298.

26.LoKW,BrashDE,FranklinWA,LippkeJA,HaseltineWA. UVLightInducedSequence SpecificDNADamageandMutagenesis. IN:HumanCarcinogenesis. 1982. 281-299.

27.LoKW,BrashDE,FranklinWA,LippkeJA,HaseltineWA. StudiesofDNADamage andMutagenesisbyUltravioletLight. IN:GenesandProteinsinOncogenesis. AcademicPress,N.Y. 1982. 41-53.

28.HaseltineWA,LenzJ,CrowtherR. DeterminationofVirulencePropertiesofLeukemia Viruses. IN:ModernTrendsinHumanLeukemiaVirus.1982. 28:451-455.

29.LoKM,FranklinWA,LippkeJA,HennerWD,HaseltineWA. NewMethodsforthe DetectionofDNADamagetoHumanCellularDNAbyEnvironmentalCarcinogensand AntitumorDrugs. IN:BanburyReport13.ColdSpringHarbor.1982. 253-263.

30.HaseltineWA,FranklinWA,LippkeJA. NewMethodsforDetectionofLowLevelsof DNADamageinHumanPopulations. IN:Env.HealthPerspectives.1983. 48:29-41.

31.SodroskiJG,LenzJR,HaseltineWA.ReflectionsandSpeculationsRegarding MechanismsofCarcinogenesis. Inserm.1983. 117:189-216.

32.HaseltineWA.SiteSpecificityofUltravioletLightInducedMutagenesis. IN:UCLA SymposiaonMolecularandCellularBiology,NewSeries.eds.ECFriedberg,BA BridgesLiss,NewYork. 1983. 11:2-33.

33.SodroskiJG,PatarcaR,LenzJ,TrusM,CrowtherR,PerkinsD,GalloR,Wong-StaalF, JosephsS,GelmanE,HaseltineWA. LTRRegionsofMurineLeukemiaVirusand HumanTCellLeukemiaVirusasPotentialLeukemogenicandPathogenicDeterminants. IN:HumanTCellLeukemia/LymphomaVirus.eds.RCGallo,MEEssex,LGross.Cold SpringHarborLabs.1983. 149-155.

34.HaseltineWA.SodroskiJG,PatarcaR. StructureandFunctionoftheGenomeofHTLV. IN:CurrentTopicsinMicrobiologyandImmunology.ed.PKVogt.Springer-Verlag, Germany. 1984. 115:177-209.

35.BisterK,BurnyAL,CroceCM,HaseltineWA,HaymanMJ,HaywardWS,KleinG, MoellingK,NethRD,PragnellIB,RowleyJD. GenesandVirusesAbletoTransform HematopoieticCells. IN:Leukemia,ed.ILWeissman.Springer-Verlag,Germany. 1983. 275292.

36.HaseltineWA,SodroskiJG,RosenCA. StructureandFunctionofHumanLeukemiaand AIDSViruses.IN:RetrovirusesinHumanLymphoma/Leukemia,ed.M.Miwa.Japan Sci.Soc.Press,Tokyo. 1985. 187-196.

37.HaseltineWA,SodroskiJG,RosenCA.ControlofGeneExpressionandtheReplication andPathogenesisofRetroviruses. IN:ImportantAdvancesinOncology.J.B.Lippincott, PA. 1986. 159-172.

38.HaseltineWA,SodroskiJG,RosenCA. ProgressandPuzzles:TheMolecularBiologyof HTLV-III.IN:AIDS:ModernConceptsandTherapeuticChallenges.ed.S.Broder. MarcelDekker,Inc.,NewYork. 1986. 53-62.

39.HaseltineWA,SodroskiJG,RosenCA,GohWC,DaytonAI,Celander DW. TransactivatorGenesofHTLV-I,II,andIII. IN:OncogenesandGrowthControl.eds.P. Kahn,T.Graf.1986,247-252. Publishers,Springer-Verlag,Heidelberg,FRG.

40.HaseltineWA,SodroskiJG. CellMembraneFusionMediatedbytheEnvelope GlycoproteinsasthePrimaryEffectorofAIDSVirusCytopathicity. IN:Acquired ImmunoDeficiencySyndrome. 1986. 47-56. (ProceedingsoftheIIInternational ConferenceonAIDS,Paris). Publisher,Elsevier.

41.HaseltineWA. ReplicationandPathogenesisofHumanRetroviruses. IN: Viral CarcinogenesisFunctionalAspects. 1986. 100-112. (ProceedingsoftheAlfredBenzon Symposium). Publisher,Munksgard,Copenhagen.

42.SodroskiJG,GohWC,RosenCA,TerwilligerE,DaytonAI,CampbellK,HaseltineWA. AFunctionalAnalysisoftheHTLV-IIIEnvelope:ImplicationsforPathogenesis,Therapy andProphylaxis.1986.(ProceedingsofColdSpringHarborMeeting,N.Y.).

43.SodroskiJG,HaseltineWA. TheAIDSVirus: PuzzlesfortheMolecularBiologist. IN: AIDSINOURLIVES: PersonalSocial,andMedicalIssues(editor,EarlHansonPPI Publishing,1989),pp7-34.

44.HaseltineWA. MolecularApproachesToPreventiveandTherapeuticInterventionfor AIDS. IN:RetrovirusesofHumanAIDSandRelatedAnimalDiseases. 1986. 5860. (ProceedingsofColloqueDesCentGardes).Publisher,PasteurVaccins,France.

45.SodroskiJG,KowalskiMK,DorfmanT,BasiripourL,RosenCA,HaseltineWA. HIV Envelope-CD4InteractionNotInhibitedbySyntheticOctapeptides. TheLancet.1987. 14281429.

46.SodroskiJG,HaseltineWA,RosenCA,PotzJ,BasiripourL,DorfmanT,KowalskiM. Structure-FunctionAnalysisoftheHumanImmunodeficiencyVirusEnvelope Glycoprotein. 1987.(ProceedingsofNIHWorkshoponPeptide"T").

47.HaseltineWA,SodroskiJG,RosenCA. ReplicationandPathogenesisoftheHuman TCellLeukemia/LymphotropicRetrovirus. IN:ModernTrendsinHumanLeukemiaVII. Springer-Verlag,Germany. 1987. 395-403.

48.HaseltineWA. ObservationsfromtheFront. IN:SIDA:EpidemiesetSocietes. 1987. 54-61.Publisher,FondationMarcelMerieux. (ProceedingsoftheFondationMarcel Merieux,Annecy).

49.HaseltineWA,SodroskiJ,TerwilligerE. ReplicationandPathogenesisofHIV-1 RetrovirusRelevanttoDrugDesign. IN:RetrovirusesandDisease. 1989. 159-181. Publisher,AcademicPress. (ProceedingsofInternationalSymposiumonMedical Virology,Irvine,CA).

50.HaseltineWA,KowalskiM,SodroskiJG. TheStructureandFunctionoftheEnvelope GlycoproteinoftheAIDSVirus. 1988. Publisher,PasteurVaccins. (Proceedingsofthe CentGardesMeeting,Paris).

51.HaseltineWA. ARationalApproachToChemotherapyofAIDS. IN:HIVandOther HighlyPathogenicViruses. 1988. 25-32.

52.EncyclopediaAmericana. AIDSArticle. 1988Edition. Publisher,GrolierIncorporated, Danbury,Connecticut.

53.SodroskiJG,KowalskiMM,HaseltineWA. StructureandFunctionoftheHuman ImmunodeficiencyVirusEnvelope: ImplicationsforVaccineDevelopment. 1988. IN: AIDSVaccine:BasicResearchandClinicalTrials. 1988.

54.SodroskiJG,HaseltineWA. TheMolecularBiologyofHIVReplicationand Pathogenesis. IN:AIDS1988(editor,RuthKulstad,AmericanAssociationforthe AdvancementofScience,1988)pp.385-400.

55.HaseltineWA,Wong-StaalF. TheMolecularBiologyoftheHumanImmunoDeficiency Virus. ScientificAmerican. 1988. 256:52-62.

56.HaseltineWA. ReplicationandPathogenesisoftheAIDSVirus. (PlenaryLecture presentedattheIVthInternationalConferenceonAIDS,Stockholm,Sweden). Journal ofAcquiredImmuneDeficiencySyndromes.1988. 1:217-240.

57.HaseltineWA,TerwilligerEF,RosenCA,SodroskiJG. StructureandFunctionof HumanPathogenicRetroviruses. IN:RetrovirusBiology:AnEmergingRoleinHuman Disease. PublishedbyMarcelDekker,Inc. 1988.

58.HaseltineWA. CurrentandFutureProspectsforAnti-ViralAIDSDrugDevelopment. (ProceedingsoftheSymposiumBiotechnologyandtheAIDSChallengein Massachusetts:ASymposiumReport). April,1989. 87-89. Sponsors:Massachusetts CentersforExcellenceCorp.,MassachusettsBiotechnologyResearchInstitute, UniversityofMassachusettsMedicalCenter,MassachusettsBiotechnologyCouncil, MassachusettsDepartmentofPublicHealth.

59.Haseltine,WilliamA. ProspectsforMedicalControloftheAIDSEpidemic. In: Daedalus:LivingwithAIDS,PartII. PublishedbyJournaloftheAmericanAcademyof ArtsandSciences. 1989. 118:1-21.

60.Haseltine,WilliamA. MolecularBiologyofHIV-1. In:AIDSandNewViruses. PublishedbyAcademicPress. 1989.

61.TerwilligerEF,HaseltineWA. RegulationofReplicationofHIV-1. 1989.

62.TerwilligerEF,SodroskiJG,HaseltineWA. MechanismsofInfectivityandReplication ofHIV-1andImplicationsforTherapy. AnnalsofEmergencyMedicine. 1989. 19: 233-241.

63.Haseltine,WA. DevelopmentofAntiviralDrugsfortheTreatmentsofAIDS:Strategies &Prospects.JournalofAcquiredDeficiencySyndromes.1989.2:311.

64.HaseltineWA. TheGeneticCode. In: Microverse. Eds.: PreissB,Alschuler,W. 1990.

65.HaseltineWA,FarnetC,GottlingerH,LanghoffE,andTerwilligerE. StudiesofHIV-1 replication. Theroleofp6,integration,andgrowthinperipheralblooddendriticcells. RetrovirusesofHumanA.I.D.S.andRelatedAnimalDiseases. Cinquieme Colloque DesCentGardes. 1990.201-212.

66.FineHA,HaseltineWA. RNATumorViruses.In: CancerMedicineTextbook. Eds.: FreiE.1991.(InPress).

67.HaseltineWA. AIDS.In: Americana. Ed: GrolierInc. 1991. (InPress).

68.HaseltineWA. HIVResearchandnefAlleles. Science. 1991.

69.HaseltineWA. TheMolecularBiologyoftheHumanImmunodeficiencyVirusType1. 1991. FASEB. 2349-2360

70.HaseltineWA. HumanImmunodeficiencyVirus(HIV)GeneExpressionandFunction. In: TheHumanRetroviruses. Ed: AcademicPress. 1991. 69-106.

71.HaseltineWA. MolecularBiologyoftheAIDSVirus: TenYearsofDiscovery-Hope fortheFuture. In: ScienceChallengingAIDS. Ed:Karger.1992. 71-106

72.HaseltineWA. ManagingtheSocio-EconomicImplicationsofGeneticEngineering.In: LeadershipandManagementintheInformationAge. TheEmiratesCenterforStrategic StudiesandResearch.2002.132-160.

Publications Edited

1. Haseltine,WA. RegulationofHIV-1Replicationbytatandrev In: GeneticStructure andRegulationofHIV-1. Eds.:HaseltineWA,Wong-StaalF RavenPress. 1991. 1-42.

2. Kalland,KH,LanghoffEL,BosHJ,GottlingerH,andHaseltineWA. Retroviral regulatoryproteinsandthenucleolus. In:GeneticStructureandRegulationofHIV-1. Eds.:HaseltineWA,Wong-StaalF RavenPress. 1991. 377-390.

3. LanghoffEL,TerwilligerE,KallandKH,PoznanskyM,BosHJ,BaconO,SodroskiJ, AndHaseltineWA. HIV-1infectionofhumandendriticcells. In: GeneticStructureand RegulationofHIV-1. Eds.: HaseltineWA,Wong-StaalF RavenPress. 1991. 511-525.

4. LuY,HeyA,TouzjianN,StenzelM,andHaseltineWA. CellularTranscriptionFactors whichRegulateHIV-1Replication. In: GeneticStructureandRegulationofHIV-1. Eds.: HaseltineWA,Wong-StaalF RavenPress. 1991. 415-435

5. HellandD,RepkeH,CaputoA,andHaseltineWA. TheExogenousTransactivation ActivityofHIV-1tat In: GeneticStructureandRegulationofHIV-1. Eds.: Haseltine WA,Wong-Staal. RavenPress.1991. 301-310

6. TerwilligerEF,LanghoffE,andHaseltineWA. ThenefGeneofHIV-1AReviewof RecentResults. In: GeneticStructureandRegulationofHIV-1. Eds.: HaseltineWA, WongStaalF RavenPress.1991. 457-471.

7. CohenEA,TerwilligerE,andHaseltineWA. ThevprProteinofHIV-1isa Virion-AssociatedPositiveRegulatoryProtein. In: GeneticStructureandRegulationof HIV-1. Eds: HaseltineWA,Wong-StaalF RavenPress.1991. 451-456